Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Helia Group’s consensus analyst fair value has shifted slightly, with the target moving from A$4.35 to about A$4.27 per share. This trim lines up with broader research across financial services, where analysts are adjusting targets but not treating Helia as an outlier. As you read on, you will see how this evolving narrative might shape the way you track Helia’s story from here. Stay updated as the Fair Value for Helia Group shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Helia Group. What Wall Street Has Been Saying 🐂 Bullish Takeaways Across recent research on financial services names like Houlihan Lokey, firms such as Goldman Sachs and Keefe Bruyette have maintained Buy or Outperform ratings even as they trim price targets. This indicates they still see scope for execution and earnings power over time. Goldman Sachs highlights that investment banking volumes are up 4% year over year through March 9, which analysts link to a healthier backdrop for deal activity. This is an important reference point when investors think about Helia’s valuation and earnings sensitivity to broader capital markets. 🐻 Bearish Takeaways UBS and Keefe Bruyette have both reduced targets on Houlihan Lokey by meaningful amounts, pointing to pressure on sector valuations as bank stocks are down about 15% year to date. This can inform how investors frame risk and potential multiple compression for Helia as well. Goldman Sachs flags that growth in investment banking volumes has slowed recently and could turn negative if geopolitical risks persist. This is a reminder that Helia’s fair value views sit within a sector where confidence can shift quickly when macro or market conditions weaken. Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!ASX:HLI 1-Year Stock Price Chart We've flagged 2 risks for Helia Group. See which could impact your investment. What's in the News Helia has issued insurance revenue guidance for fiscal 2026 in a range of A$320 million to A$370 million, providing a clearer indication of how management is sizing the business for that year. The board has declared a partially franked final special dividend of A$0.67 per share, with shares trading ex dividend from 10 March 2026 and payment scheduled for 26 March 2026. Helia has completed a share buyback that retired 19,266,911 shares, or 6.65% of the company, for a total cost of A$79.29 million under the program first announced on 10 May 2024. Story Continues How This Changes the Fair Value For Helia Group Fair value target adjusted from A$4.35 to about A$4.27 per share. Forecast revenue change revised from a 15.35% decline to an 18.79% decline. Expected net profit margin updated from 37.86% to about 42.48%. Future P/E multiple moved from 13.39x to about 13.12x. Discount rate refined from 7.08% to about 7.05%. Never Miss an Update: Follow The Narrative Narratives link a company’s real world story to the forecasts and fair value estimates you see on screen. They update as new data, guidance, and sector views come through so you can see what is driving the numbers. Head over to the Simply Wall St Community and follow the Narrative on Helia Group to stay up to date on: How the loss of major lender clients like Commonwealth Bank and ING, which recently made up 61% of gross written premium, could affect new business volumes from 2026. The impact of the expanded Home Guarantee Scheme and other government or lender backed solutions on Helia’s addressable mortgage insurance market. The extent to which Helia’s strong capital position, large back book of in force policies, and low claims environment can offset pressure on future revenue and earnings. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include HLI.AX. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
How The Evolving Investment Narrative Is Reframing Helia Group’s (ASX:HLI) Fair Value Story
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...